Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

Interventional Approaches to Septal Reduction Therapy

Presenter: Srihari S. Naidu

June 07, 2024

Presentation NY Valves 2024

Is there Still a Role for Surgery in HCM?

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

Myosin Inhibitors and Novel Medical Therapies for HCM

Presenter: Mark V. Sherrid

June 07, 2024

Presentation NY Valves 2024

The SESAME Procedure for Obstructive HCM.

Presenter: Jaffar M. Khan

June 07, 2024

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Presenter: Taha Hatab

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Presenter: Atsushi Okada

June 07, 2024

Presentation NY Valves 2024

Redo Mitral Valve-in-Valve Intervention: Not All Failures Are the Same!

Presenter: Curtiss T. Stinis

June 07, 2024

Presentation NY Valves 2024

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Presenter: Joao L. Cavalcante

June 07, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Presenter: David A. Wood

June 06, 2024

Advertisement

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

National Data Point to Soaring TAVI Rates in Patients Under 65

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Interventional Approaches to Septal Reduction Therapy

Is there Still a Role for Surgery in HCM?

Myosin Inhibitors and Novel Medical Therapies for HCM

The SESAME Procedure for Obstructive HCM.

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Redo Mitral Valve-in-Valve Intervention: Not All Failures Are the Same!

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content